Skip to main content

Bamlanivimab / etesevimab User Reviews & Ratings

Brand names: bamlanivimab and etesevimab

Bamlanivimab / etesevimab has an average rating of 1.0 out of 10 from a total of 1 reviews on Drugs.com. 0% of reviewers reported a positive experience, while 100% reported a negative experience.

Write a review

  • Cov...
  • Taken for less than 1 month
  • July 29, 2022

For COVID-19 "I was on day 7 of COVID with mild symptoms, and 2 hours after I received the monoclonals, my heart rate spiked, and I went to the hospital. I had a massive inflammatory response. I developed pericarditis and costochondritis. It’s now 7 months later, and I am still having significant heart problems and now have heart disease."

1 / 10
Was this helpful?YesNo
2 Report

Are you taking this medicine?

Your review helps others make informed decisions.
Write a review
Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.

More about bamlanivimab / etesevimab

Patient resources

Other brands

bamlanivimab and etesevimab

Professional resources

Related treatment guides